Related Experiment Video
Updated: May 9, 2025

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Using sleep to enhance exposure treatment for anxious children: A pilot study
Ella L Oar1, Ronald M Rapee1, Cassie H Lavell1
1Lifespan Health and Wellbeing Research Centre, School of Psychological Sciences, Macquarie University, Sydney, New South Wales, Australia.
Objectives:
Exposure therapy is a well-established treatment for anxiety disorders in children; however, many young people do not fully respond to treatment. Advances in strategies to enhance extinction learning from exposure therapy are urgently needed. Emerging adult research suggests that sleep could be used to augment exposure therapy outcomes. To the best of our knowledge, the current study is the first published pilot evaluation of the potential benefits of sleep to enhance extinction learning in anxious children.
Methods:
Eighteen children aged 7-12 years (M = 9.11; 38.9% Male) with a primary diagnosis of an anxiety disorder were randomized to either a period of sleep immediately following a single session of exposure (SLEEP group), or a day of wakefulness following exposure (WAKE group).
Results:
Both groups improved on clinician-rated anxiety severity and children's danger severity expectancies from pre-treatment to post-treatment and 1-week follow-up. Child- and parent-rated target symptom fear ratings also improved from pre-treatment to 1-week follow-up. However, there was no evidence that children in the SLEEP group improved significantly more than the WAKE group.
Conclusions:
The current pilot study failed to demonstrate an augmentation effect of post-exposure sleep in children. Practical and methodological challenges are reported for consideration in future investigations.
More Related Videos
08:08Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory
Published on: June 18, 2014
08:20Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
Related Concept Videos
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Insomnia
Multiple factors contribute...